Kettering Health using 3 clinical trials in treatment of COVID-19 patients

Miami Valley News

KETTERING, Ohio (WDTN) – Kettering Health Network is using three different clinical trials as they care for COVID-19 patients.

  1. IL-6 inhibitor ruxolitinib: This drug appears to slow immune system problems that occur in some COVID-19 patients.
  2. Convalescent plasma trial: Plasma donated by patients that have recovered from COVID-19 is given to current COVID-19 patients. The antibodies in the plasma support the patient’s recovery. This effort is being led by the Mayo Clinic.
  3. Remdesivir: An anti-rival drug, which has shown in preliminary trials to help COVID-19 patients recover more quickly

“We’ve got a lot more testing available to us now, so it certainly allows us to test more of the patients in the hospital. It’s allowing us to start testing patients before surgery, and I think on a larger note it’s giving us a better idea of the prevalence of the disease within our communities,” said Infectious Disease Specialist Jeffrey Weinstein.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More As Seen on 2 NEWS

Trending Stories

Don't Miss

More stories not to miss...


More BestReviews

Latest News Videos

Storm Team 2 Forecast

What Ohio COVID-19 hospitalizations could indicate about reaching peak in cases

50th Annual Oktoberfest, Dayton Art Institute

The Senior Food Box Program, Keeping Elderly fed in Dayton

Push for horseless carriages after scary incident

Yale Ph.D. student coming up on $1 million in winnings in 27-day streak on Jeopardy!

More News